Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,651 | 65,071 | 79,737 | 86,327 | 87,777 |
| Receivables | 34,682 | 36,737 | 30,629 | 34,627 | 34,168 |
| Inventories | 43,724 | 42,604 | 41,319 | 39,765 | 37,237 |
| TOTAL | $156,778 | $152,201 | $160,331 | $169,547 | $167,761 |
| Non-Current Assets | |||||
| PPE Net | 45,937 | 47,988 | 48,803 | 48,279 | 47,390 |
| Intangibles | 76,015 | 78,174 | 80,115 | 81,938 | 83,266 |
| Other Non-Current Assets | 49,428 | 50,519 | 49,825 | 49,364 | 49,329 |
| TOTAL | $171,380 | $176,681 | $178,743 | $179,581 | $179,985 |
| Total Assets | $328,158 | $328,882 | $339,074 | $349,128 | $347,746 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,251 | 7,944 | 8,948 | 9,074 | 8,353 |
| Accrued Expenses | 19,813 | 15,512 | 19,745 | 18,840 | 17,999 |
| TOTAL | $28,064 | $23,456 | $28,693 | $27,914 | $26,352 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 27,653 | 28,176 | 28,679 | 29,215 | 29,657 |
| TOTAL | $29,608 | $31,411 | $32,793 | $35,651 | $36,457 |
| Total Liabilities | $57,672 | $54,867 | $61,486 | $63,565 | $62,809 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,641 | 14,631 | 14,757 | 14,633 | 14,610 |
| Common Shares | 146 | 147 | 147 | 146 | 146 |
| Retained earnings | 191,052 | 197,628 | 200,369 | 210,719 | 215,627 |
| Other shareholders' equity | -6,564 | -6,157 | -6,171 | -6,443 | -7,497 |
| TOTAL | $270,486 | $274,015 | $277,588 | $285,563 | $284,937 |
| Total Liabilities And Equity | $328,158 | $328,882 | $339,074 | $349,128 | $347,746 |